{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T20:05:13Z","timestamp":1793390713233,"version":"4.5.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T00:00:00Z","timestamp":1621987200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004243","name":"Prinses Beatrix Spierfonds","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004243","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","nmd-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuromuscular Disorders"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.nmd.2021.05.006","type":"journal-article","created":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T11:11:48Z","timestamp":1622286708000},"page":"622-632","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Accuracy of patient-reported data for an online patient registry of autoimmune myasthenia gravis and Lambert-Eaton myasthenic syndrome"],"prefix":"10.1016","volume":"31","author":[{"given":"Annabel M.","family":"Ruiter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"Strijbos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.P.","family":"de Meel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander F.","family":"Lipka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter F.","family":"Raadsheer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn R.","family":"Tannemaat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan J.G.M.","family":"Verschuuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.nmd.2021.05.006_bib0001","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1212\/WNL.0000000000000563","article-title":"European database for myasthenia gravis: a model for an international disease registry","volume":"83","author":"Fulvio","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.nmd.2021.05.006_bib0002","series-title":"Registries for evaluating patient outcomes: a user's guide","article-title":"AHRQ methods for effective health care","author":"Gliklich","year":"2010"},{"issue":"1","key":"10.1016\/j.nmd.2021.05.006_bib0003","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1186\/s13104-017-2840-1","article-title":"A first description of the Colombian national registry for rare diseases","volume":"10","author":"Mateus","year":"2017","journal-title":"BMC Res Notes"},{"issue":"11","key":"10.1016\/j.nmd.2021.05.006_bib0004","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1212\/WNL.26.11.1054","article-title":"Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value","volume":"26","author":"Lindstrom","year":"1976","journal-title":"Neurology"},{"issue":"5\u20136","key":"10.1016\/j.nmd.2021.05.006_bib0005","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3109\/08916931003602130","article-title":"Clinical aspects of myasthenia explained","volume":"43","author":"Verschuuren","year":"2010","journal-title":"Autoimmunity"},{"issue":"10","key":"10.1016\/j.nmd.2021.05.006_bib0006","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S1474-4422(15)00145-3","article-title":"Myasthenia gravis: subgroup classification and therapeutic strategies","volume":"14","author":"Gilhus","year":"2015","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1016\/j.nmd.2021.05.006_bib0007","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1212\/01.WNL.0000130254.27019.14","article-title":"The epidemiology of the lambert-eaton myasthenic syndrome in the Netherlands","volume":"63","author":"Wirtz","year":"2004","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.nmd.2021.05.006_bib0008","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1007\/s00415-017-8541-9","article-title":"Lambert-eaton myasthenic syndrome (LEMS): a rare autoimmune presynaptic disorder often associated with cancer","volume":"264","author":"Schoser","year":"2017","journal-title":"J Neurol"},{"issue":"7","key":"10.1016\/j.nmd.2021.05.006_bib0009","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1200\/JCO.2010.32.0440","article-title":"Clinical dutch-english lambert-eaton myasthenic syndrome (LEMS) tumor association prediction score accurately predicts small-cell lung cancer in the LEMS","volume":"29","author":"Titulaer","year":"2011","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.nmd.2021.05.006_bib0010","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1136\/jnnp.73.6.766","article-title":"Difference in distribution of muscle weakness between myasthenia gravis and the lambert-eaton myasthenic syndrome","volume":"73","author":"Wirtz","year":"2002","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"4","key":"10.1016\/j.nmd.2021.05.006_bib0011","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/S1474-4422(14)70201-7","article-title":"Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment","volume":"14","author":"Engel","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nmd.2021.05.006_bib0012","article-title":"Congenital myasthenia syndrome in a Chinese family with mutations in MUSK: a hotspot mutation and literature review","author":"Liu","year":"2020","journal-title":"J Clin Neurosci"},{"key":"10.1016\/j.nmd.2021.05.006_bib0013","doi-asserted-by":"crossref","DOI":"10.1002\/mus.26695","article-title":"Cross-sectional analysis of the myasthenia gravis patient registry: disability and treatment","author":"Cutter","year":"2019","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nmd.2021.05.006_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.116830","article-title":"Exploring outcomes and characteristics of myasthenia gravis: rationale, aims and design of registry-the explore-MG registry","volume":"414","author":"Anil","year":"2020","journal-title":"J Neurol Sci"},{"issue":"1","key":"10.1016\/j.nmd.2021.05.006_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nrl.2014.09.007","article-title":"Prevalence of myasthenia gravis in the Catalan county of Osona","volume":"32","author":"Aragones","year":"2017","journal-title":"Neurologia"},{"issue":"12","key":"10.1016\/j.nmd.2021.05.006_bib0016","first-page":"309","article-title":"[Japan MG registry study: a sophisti- cated multi-center study of myasthe- nia gravis a sophisticated multi-center study of myasthenia gravis]","volume":"106","author":"Murai","year":"2015","journal-title":"Fukuoka Igaku Zasshi"},{"issue":"7","key":"10.1016\/j.nmd.2021.05.006_bib0017","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1111\/ene.12703","article-title":"Myasthenia gravis: descriptive analysis of life-threatening events in a recent nationwide registry","volume":"22","author":"Ramos-Fransi","year":"2015","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.nmd.2021.05.006_bib0018","unstructured":"[Available from: https:\/\/www.lumc.nl\/org\/neurologie\/research\/myasthenie-register\/."},{"issue":"5","key":"10.1016\/j.nmd.2021.05.006_bib0019","doi-asserted-by":"crossref","first-page":"e511","DOI":"10.1212\/WNL.0000000000008747","article-title":"Long-term follow-up, quality of life, and survival of patients with lambert-eaton myasthenic syndrome","volume":"94","author":"Lipka","year":"2020","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.nmd.2021.05.006_bib0020","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1056\/NEJMoa1602489","article-title":"Randomized trial of thymectomy in myasthenia gravis","volume":"375","author":"Wolfe","year":"2016","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.nmd.2021.05.006_bib0021","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/mus.20950","article-title":"Lifetime course of myasthenia gravis","volume":"37","author":"Grob","year":"2008","journal-title":"Muscle Nerve"},{"issue":"26","key":"10.1016\/j.nmd.2021.05.006_bib0022","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.1056\/NEJMra1602678","article-title":"Myasthenia gravis","volume":"375","author":"Gilhus","year":"2016","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.nmd.2021.05.006_bib0023","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jaut.2009.09.008","article-title":"Recent insights in the epidemiology of autoimmune diseases: improved prevalence estimates and understanding of clustering of diseases","volume":"33","author":"Cooper","year":"2009","journal-title":"J Autoimmun"},{"issue":"1","key":"10.1016\/j.nmd.2021.05.006_bib0024","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/ene.12599","article-title":"Myasthenia gravis and risks for comorbidity","volume":"22","author":"Gilhus","year":"2015","journal-title":"Eur J Neurol"},{"issue":"1\u20132","key":"10.1016\/j.nmd.2021.05.006_bib0025","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jneuroim.2011.05.008","article-title":"Concomitant autoimmunity in myasthenia gravis-lack of association with IgA deficiency","volume":"236","author":"Ramanujam","year":"2011","journal-title":"J Neuroimmunol"},{"issue":"10","key":"10.1016\/j.nmd.2021.05.006_bib0026","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s00415-004-0528-7","article-title":"Associated autoimmune diseases in patients with the lambert-eaton myasthenic syndrome and their families","volume":"251","author":"Wirtz","year":"2004","journal-title":"J Neurol"},{"key":"10.1016\/j.nmd.2021.05.006_bib0027","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jneuroim.2015.03.018","article-title":"Prognostic factors for exacerbations and emergency treatments in myasthenia gravis","volume":"282","author":"de Meel","year":"2015","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.nmd.2021.05.006_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.nmd.2021.04.002","article-title":"Prevalence and associated factors of fatigue in autoimmune myasthenia gravis","author":"Ruiter","year":"2021","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"10.1016\/j.nmd.2021.05.006_bib0029","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3233\/JND-180355","article-title":"Pattern of habitual physical exercise in myasthenia gravis patients","volume":"6","author":"O'Connor","year":"2019","journal-title":"J Neuromuscul Dis"},{"issue":"2","key":"10.1016\/j.nmd.2021.05.006_bib0030","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.nmd.2019.12.003","article-title":"Emerging therapies for autoimmune myasthenia gravis: towards treatment without corticosteroids","volume":"30","author":"Tannemaat","year":"2020","journal-title":"Neuromuscul Disord"},{"issue":"3","key":"10.1016\/j.nmd.2021.05.006_bib0031","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S1474-4422(18)30392-2","article-title":"Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial","volume":"18","author":"Wolfe","year":"2019","journal-title":"Lancet Neurol"},{"issue":"4","key":"10.1016\/j.nmd.2021.05.006_bib0032","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1212\/WNL.0000000000002790","article-title":"International consensus guidance for management of myasthenia gravis: executive summary","volume":"87","author":"Sanders","year":"2016","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.nmd.2021.05.006_bib0033","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/mus.26404","article-title":"Thymectomy may not be associated with clinical improvement in MuSK myasthenia gravis","volume":"59","author":"Clifford","year":"2019","journal-title":"Muscle Nerve"},{"issue":"3","key":"10.1016\/j.nmd.2021.05.006_bib0034","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.nmd.2021.05.006_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2019.116520","article-title":"Hospital admission and prevalence trends of adult myasthenia gravis in Finland in 2004-2014: a retrospective national registry study","volume":"407","author":"Sipila","year":"2019","journal-title":"J Neurol Sci"},{"issue":"Pt 10","key":"10.1016\/j.nmd.2021.05.006_bib0036","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/brain\/awg223","article-title":"Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis","volume":"126","author":"Evoli","year":"2003","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.nmd.2021.05.006_bib0037","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1080\/07853890.2018.1461919","article-title":"Adult hospital admissions associated with multiple sclerosis in Finland in 2004\u20132014","volume":"50","author":"Pirttisalo","year":"2018","journal-title":"Ann Med"},{"issue":"6","key":"10.1016\/j.nmd.2021.05.006_bib0038","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/mus.25624","article-title":"Inpatient cost analysis for treatment of myasthenia gravis","volume":"56","author":"Omorodion","year":"2017","journal-title":"Muscle Nerve"}],"container-title":["Neuromuscular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896621001310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0960896621001310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T08:11:27Z","timestamp":1760775087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0960896621001310"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S0960896621001310"],"URL":"https:\/\/doi.org\/10.1016\/j.nmd.2021.05.006","relation":{},"ISSN":["0960-8966"],"issn-type":[{"value":"0960-8966","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Accuracy of patient-reported data for an online patient registry of autoimmune myasthenia gravis and Lambert-Eaton myasthenic syndrome","name":"articletitle","label":"Article Title"},{"value":"Neuromuscular Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nmd.2021.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}